These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2226108)

  • 1. Insulin use in NIDDM. Rationale based on pathophysiology of disease.
    Turner RC; Holman RR
    Diabetes Care; 1990 Sep; 13(9):1011-20. PubMed ID: 2226108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin therapy in type II diabetes.
    Holman RR; Turner RC
    Diabetes Res Clin Pract; 1995 Aug; 28 Suppl():S179-84. PubMed ID: 8529512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of NIDDM with insulin agonists or substitutes.
    Galloway JA
    Diabetes Care; 1990 Dec; 13(12):1209-39. PubMed ID: 1980453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvement of basal hepatic glucose production and fasting hyperglycemia of type I diabetic patients treated with human recombinant ultralente insulin.
    Riccio A; Avogaro A; Valerio A; Zappella A; Tiengo A; Del Prato S
    Diabetes Care; 1994 Jun; 17(6):535-40. PubMed ID: 8082521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-insulin-dependent diabetes mellitus: a clinical strategy.
    Skyler JS
    Diabetes Care; 1984; 7 Suppl 1():118-29. PubMed ID: 6376024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin secretion and insulin action in non-insulin-dependent diabetes mellitus: which defect is primary?
    Reaven GM
    Diabetes Care; 1984; 7 Suppl 1():17-24. PubMed ID: 6376025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fasting plus prandial insulin supplements improve insulin secretory ability in NIDDM subjects.
    Kawamori R; Bando K; Yamasaki Y; Kubota M; Watarai T; Iwama N; Shichiri M; Kamada T
    Diabetes Care; 1989; 12(10):680-5. PubMed ID: 2515048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin use in NIDDM.
    Genuth S
    Diabetes Care; 1990 Dec; 13(12):1240-64. PubMed ID: 2276309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathophysiology of insulin secretion in non-insulin-dependent diabetes mellitus.
    Ward WK; Beard JC; Halter JB; Pfeifer MA; Porte D
    Diabetes Care; 1984; 7(5):491-502. PubMed ID: 6094129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin treatment of non-insulin-dependent diabetes mellitus.
    Heine RJ
    Baillieres Clin Endocrinol Metab; 1988 May; 2(2):477-92. PubMed ID: 3075903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral antidiabetic agents: current role in type 2 diabetes mellitus.
    Krentz AJ; Bailey CJ
    Drugs; 2005; 65(3):385-411. PubMed ID: 15669880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type II diabetes mellitus.
    Edelman SV
    Adv Intern Med; 1998; 43():449-500. PubMed ID: 9506190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Banting lecture 1990. Beta-cells in type II diabetes mellitus.
    Porte D
    Diabetes; 1991 Feb; 40(2):166-80. PubMed ID: 1991568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ambient plasma free fatty acid concentrations in noninsulin-dependent diabetes mellitus: evidence for insulin resistance.
    Fraze E; Donner CC; Swislocki AL; Chiou YA; Chen YD; Reaven GM
    J Clin Endocrinol Metab; 1985 Nov; 61(5):807-11. PubMed ID: 3900120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relative hyperproinsulinemia of NIDDM persists despite the reduction of hyperglycemia with insulin or sulfonylurea therapy.
    Rachman J; Levy JC; Barrow BA; Manley SE; Turner RC
    Diabetes; 1997 Oct; 46(10):1557-62. PubMed ID: 9313749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of exercise training in the prevention and treatment of insulin resistance and non-insulin-dependent diabetes mellitus.
    Ivy JL
    Sports Med; 1997 Nov; 24(5):321-36. PubMed ID: 9368278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of conventional and intensified insulin therapy on free-insulin profiles and glycemic control in NIDDM.
    Lindström TH; Arnqvist HJ; von Schenck HH
    Diabetes Care; 1992 Jan; 15(1):27-34. PubMed ID: 1737539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of hyperglycemia on insulin's in vivo effects in type II diabetes.
    Revers RR; Fink R; Griffin J; Olefsky JM; Kolterman OG
    J Clin Invest; 1984 Mar; 73(3):664-72. PubMed ID: 6368585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of basal insulin supplementation on disposition of mixed meal in obese patients with NIDDM.
    McMahon M; Marsh HM; Rizza RA
    Diabetes; 1989 Mar; 38(3):291-303. PubMed ID: 2492963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fasting hyperglycemia: etiology, diagnosis, and treatment.
    Sheehan JP
    Diabetes Technol Ther; 2004 Aug; 6(4):525-33. PubMed ID: 15321011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.